DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Ambix Venture Management, LLC
Ambix Venture Management, LLC
venture manager, reported GAV $95M across 3 vehicles
Importance
17
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
63
high
Freshness
99
high
Research priority
9
low
Identity and regulatory footprint
- Headquarters
- Mountain View, CAadviserinfo.sec.gov
- Office address
- 627 NATIONAL AVENUE, Mountain View, CA, 94043adviserinfo.sec.gov
- Business phone
- 858-349-8705adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 27, 2026
- Private funds reported
- 3 (3 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $95.4Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@ambixventures.comambixventures.compublished by the subject
- business phone
- 858-349-8705adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- early, multi stage
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Ambix Life Science Fund I-B, L.P. | Feeder or parallel | 2023 adv first reported | Active deployment | $15.5M Mar 29, 2024 | 16 | unknown | unknown |
| Ambix Life Science Fund I-A, L.P. | Feeder or parallel | 2023 adv first reported | Active deployment | $13.9M Mar 29, 2024 | 20 | unknown | unknown |
| Ambix Life Science Fund I, L.P. | Fund | unknown | Unknown | $66.1M Mar 29, 2024 | 40 | $0 of $250M | Apr 29, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
4 current, 0 departed
Peter Norton Townshend
Managing partnerManaging Member · since May 1, 2020
Aaron Berez
PartnerCo-Founder and Managing Director
Aaron Lee Berez
PartnerMember · since May 1, 2020
Peter Townshend
PartnerCo-Founder and Managing Director
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Mar 30, 2023Ambix Life Science Fund I-B, L.P. first reported on Form ADV by Ambix Venture Management, LLC (Venture Capital Fund), GAV $15,457,016Fund first reported on Form ADVFundsFactAmbix Life Science Fund I-B, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2023Ambix Life Science Fund I-A, L.P. first reported on Form ADV by Ambix Venture Management, LLC (Venture Capital Fund), GAV $13,202,432Fund first reported on Form ADVFundsFactAmbix Life Science Fund I-A, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 20, 2022Ambix Venture Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 20, 2022Ambix Life Science Fund I, L.P. first reported on Form ADV by Ambix Venture Management, LLC (Venture Capital Fund), GAV $25,000,000Fund first reported on Form ADVFundsFactAmbix Life Science Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $95M across 3 vehicles
Evidence
43 observations from 3 sources